Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 4/20 | 0.53 |
| ▸ | NR4A2 | P43354 | 5/20 | 0.46 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.41 |
| ▸ | TUBB | P07437 | 2/20 | 0.41 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.41 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.41 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.41 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.41 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.41 |
| ▸ | TUBB2A | Q13885 | 2/20 | 0.41 |
| ▸ | TUBB8 | Q3ZCM7 | 2/20 | 0.41 |
| ▸ | TUBA3E | Q6PEY2 | 2/20 | 0.41 |
| ▸ | TUBA1A | Q71U36 | 2/20 | 0.41 |
| ▸ | TUBA1C | Q9BQE3 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1399284 | 0.91 | IDO1 (0.66) | IDO1NR4A2CREBBPMAPTSLC6A4 | |
| SCHEMBL1399355 | 0.86 | IDO1 (0.47) | IDO1SLC6A4SLC6A3 | |
| SCHEMBL1399233 | 0.83 | ALDH1A1 (0.48) | IDO1MAPTSLC6A4 | |
| SCHEMBL4448426 | 0.81 | SLC6A4 (0.51) | MAPTSLC6A4SLC6A3POLBHSD17B10 | |
| SCHEMBL4235843 | 0.79 | NR4A2 (0.70) | NR4A2CREBBPMAPTMAP2K4 | |
| SCHEMBL1399340 | 0.76 | IDO1 (0.59) | IDO1SLC6A4SLC6A3POLBTUBB4A | |
| SCHEMBL757235 | 0.76 | IDO1 (0.52) | IDO1SLC6A4TUBB4ATUBBTUBA3C | |
| SCHEMBL4440485 | 0.76 | HSD17B10 (0.64) | MAPTSLC6A4SLC6A3POLBHSD17B10 | |
| SCHEMBL18795730 | 0.75 | SLC6A4 (0.46) | MAPTSLC6A4SLC6A3POLBHSD17B10 | |
| SCHEMBL4069370 | 0.75 | MAPT (0.45) | IDO1MAPTSLC6A4SLC6A3POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8138220-B2 | [2-(6-fluoro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders | H. LUNDBECK A/S (DK) | 2012-03-20 | — | — | US | claimed |
| US-20090326036-A1 | [2-(6-FLUORO-1H-INDOL-3-YLSULFANYL)BENZYL]METHYL AMINE FOR THE TREATMENT OF AFFECTIVE DISORDERS | H. LUNDBECK A/S (DK) | 2009-12-31 | — | — | US | claimed |
| EP-2074091-A1 | [2-(6-FLOURO-1H-INDOL-3-YLSULFANYL)BENZYL]METHYL AMINE FOR THE TREATMENT OF AFFECTIVE DISORDERS | H. Lundbeck A/S (DK) | 2009-07-01 | — | — | EP | claimed |
| WO-2008037258-A1 | [2-(6-FLOURO-1H-INDOL-3-YLSULFANYL)BENZYL]METHYL AMINE FOR THE TREATMENT OF AFFECTIVE DISORDERS | H. LUNDBECK A/S (DK) | 2008-04-03 | — | — | WO | claimed |
| EP-2074091-B1 | [2-(6-FLOURO-1H-INDOL-3-YLSULFANYL)BENZYL]METHYL AMINE FOR THE TREATMENT OF AFFECTIVE DISORDERS | LUNDBECK & CO AS H (DK) | 2015-01-07 | — | — | EP | disclosed |
| US-8138220-B2 | [2-(6-fluoro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders | H. LUNDBECK A/S (DK) | 2012-03-20 | — | — | US | disclosed |
| US-8138220-B2 | [2-(6-fluoro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders | H. LUNDBECK A/S (DK) | 2012-03-20 | — | — | US | disclosed |
| US-8138220-B2 | [2-(6-fluoro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders | H. LUNDBECK A/S (DK) | 2012-03-20 | — | — | US | disclosed |
| US-20090326036-A1 | [2-(6-FLUORO-1H-INDOL-3-YLSULFANYL)BENZYL]METHYL AMINE FOR THE TREATMENT OF AFFECTIVE DISORDERS | H. LUNDBECK A/S (DK) | 2009-12-31 | — | — | US | disclosed |
| US-20090326036-A1 | [2-(6-FLUORO-1H-INDOL-3-YLSULFANYL)BENZYL]METHYL AMINE FOR THE TREATMENT OF AFFECTIVE DISORDERS | H. LUNDBECK A/S (DK) | 2009-12-31 | — | — | US | disclosed |
| US-20090326036-A1 | [2-(6-FLUORO-1H-INDOL-3-YLSULFANYL)BENZYL]METHYL AMINE FOR THE TREATMENT OF AFFECTIVE DISORDERS | H. LUNDBECK A/S (DK) | 2009-12-31 | — | — | US | disclosed |
| WO-2009112541-A2 | [2-(6-FLOURO-1H-INDOL-3-YLSULFANYL)BENZYL]METHYL AMINE FOR THE TREATMENT OF AFFECTIVE DISORDERS | H. LUNDBECK A/S (DK) | 2009-09-17 | — | — | WO | disclosed |
| EP-2074091-A1 | [2-(6-FLOURO-1H-INDOL-3-YLSULFANYL)BENZYL]METHYL AMINE FOR THE TREATMENT OF AFFECTIVE DISORDERS | H. Lundbeck A/S (DK) | 2009-07-01 | — | — | EP | disclosed |
| WO-2008037258-A1 | [2-(6-FLOURO-1H-INDOL-3-YLSULFANYL)BENZYL]METHYL AMINE FOR THE TREATMENT OF AFFECTIVE DISORDERS | H. LUNDBECK A/S (DK) | 2008-04-03 | — | — | WO | disclosed |
| WO-2008037258-A1 | [2-(6-FLOURO-1H-INDOL-3-YLSULFANYL)BENZYL]METHYL AMINE FOR THE TREATMENT OF AFFECTIVE DISORDERS | H. LUNDBECK A/S (DK) | 2008-04-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090326036-A1 | [2-(6-FLUORO-1H-INDOL-3-YLSULFANYL)BENZYL]METHYL AMINE FOR THE TREATMENT OF AFFECTIVE DISORDERS | HTR2C, HTR3B, HTR3C | IDO1 108/4885NR4A2 1388/4885CREBBP 2809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.